On line services
Press area
AEPI area
Partners area
Nanobio
Nanobio’s originality lies in the fact that it brings together researchers from different disciplines – engineers, biologists, physicists, chemists and medical doctors – to develop new miniaturized tools (biochips, lab-on-chips, biosensors) to improve the analysis, diagnosis and treatment of numerous diseases.
Origins
NanoBio was started in 2001 by CEA-Grenoble and Université Joseph Fourier, with the financial support of local authorities. It is a centre for innovation in micro and nanotechnology applied to biology and healthcare.Players
NanoBio is a federation of research (over 300 researchers working in biology, chemistry, electronics, etc.) and training organizations, and firms operating in and around Grenoble. It was set up to function in synergy with Minatec and is based at three main sites:
- Grenoble's Science Park, with researchers from CEA-Leti and Minatec, and teams working in basic research in physics and biology jointly supported by several organizations (CEA, UJF, Inserm, CNRS);
- The university campus in Saint Martin d’Hères, with a large number of basic research teams (CNRS, UJF) in chemistry and physics, at the interface with biology, and in chemistry-related R&D and transfer activities;
- The medical campus at La Tronche, with mixed UJF/CNRS/Inserm and CHU-Grenoble teams, whose main role is to provide input on demand and to validate prototype tools developed by NanoBio researchers in a clinical context.
Applications
These advanced technologies hold the promise of a wide range of applications including medical diagnosis, the development of new drugs, supervision of diet, bacterial analysis of water, diagnosis outside the laboratory, etc. In the foreseeable future the market for nanobiotechnology R&D should exceed several billion euros.